Search

Displaying results 5841 - 5850 of 8412 in total
  1. Drug

    Suvodirsen

    go.drugbank.com/drugs/DB17940
    Investigational

    Suvodirsen is an antisense oligonucleotide that has been investigated for the treatment of Duchenne muscular dystrophy.

  2. Drug

    REM-422

    go.drugbank.com/drugs/DB19304
    Investigational

    REM-422 is an orally bioavailable, small molecule mRNA degrader of the proto-oncogene c-Myb.

  3. Drug

    AER001

    go.drugbank.com/drugs/DB05078
    Investigational

    AER001, an IL4/13 receptor antagonist for severe asthma and eczema currently in Phase 2 studies.

  4. Drug

    1-deoxymannojirimycin

    go.drugbank.com/drugs/DB03955
    Experimental

    An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity. [PubChem]

    Synonyms: D-manno-Deoxynojirimycin
  5. Drug

    Alcuronium

    go.drugbank.com/drugs/DB13648
    Experimental

    It is used as an anesthesia adjuvant.

  6. Drug

    DTX-101

    go.drugbank.com/drugs/DB17699
    Investigational

    DTX-101 is an investigational gene therapy consisting of an adeno-associated virus serotype Rh10 vector encoding the human Factor Ix gene.

  7. Drug

    Tesevatinib

    go.drugbank.com/drugs/DB11973
    Investigational

    In addition, tesevatinib inhibits EphB4, an RTK that is highly expressed in many human tumors and plays a role in promoting angiogenesis.

  8. Drug

    Parathyroid hormone

    go.drugbank.com/drugs/DB05829
    ApprovedInvestigational

    Available as Preotact, it is an identical form of human recombinant hormome which produced as a fusion protein undergoeing post-translational processing involving the cleavage of the OmpA leader sequence

  9. Drug

    Sedecamycin

    go.drugbank.com/drugs/DB21342
    Experimental

    Sedecamycin has a monoisotopic molecular weight of 501.24 Da.

  10. Drug

    Cianopramine

    go.drugbank.com/drugs/DB19470
    Experimental

    Cianopramine has a monoisotopic molecular weight of 305.19 Da.